Dr. Xuechao Xing was a Senior Research Scientist and Instructor at the LDDN. Having joined the LDDN in 2001, Xuechao made major contributions to multiple LDDN projects including necrosis inhibitors, BMP, SMA, and EAAT2. Xuechao is currently working as a medicinal chemist at Enanta Pharmaceuticals in Watertown, MA.
Dr. Hrvoje (Harry) Lusic joined the LDDN as a postdoctoral research fellow in medicinal chemistry in 2013.
Harry made many key contributions to multiple projects including for SMA, CMT, ALS and Alzheimer's disease. Harry left the LDDN in 2017 and is teaching at North Carolina A&T University in Greensboro.
Dr. Xiao (Elliot) Wang was a Researcher and Instructor at the LDDN.
Dr. Wang originally joined the LDDN as a postdoctoral Research Fellow in Medicinal Chemistry in 2011, and was promoted to Instructor in 2012. His research efforts were aimed at optimizing small molecules for the Klotho and EAAT2 projects as potential treatments for neurodegeneration. In 2017 Elliot returned to China to continue his research career.
Alyssa originally joined the LDDN in January 2014 as a Northeastern coop student and after graduation from Northeastern in 2015 she rejoined the LDDN as a Research Associate. Alyssa made many important contributions to the SMA project. In 2017 she left the LDDN to begin her medical career at Drexel University College of Medicine.